FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

385101003: Ointment (basic dose form)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479363017 Ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3534592017 Ointment (basic dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ointment Is a Type of drug preparation false Inferred relationship Existential restriction modifier
Ointment Is a Basic dose form with semi-solid state of matter true Inferred relationship Existential restriction modifier
Ointment Has state of matter Semi-solid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lasonil 0.8% ointment (Bayer Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Liquid paraffin 50% / White soft paraffin 50% ointment (J M Loveridge Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Liquid paraffin 50% / White soft paraffin 50% ointment (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
White soft paraffin 50% / Liquid paraffin 50% ointment (Kent Pharma (UK) Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Liquid paraffin 50% / White soft paraffin 50% ointment (Thornton & Ross Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment 120 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Tri-Adcortyl ointment 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Tri-Adcortyl ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
White soft paraffin 95% / Liquid paraffin 5% ointment 50 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Diprobase ointment (Schering-Plough Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Chlortetracycline 3.09% / Triamcinolone acetonide 0.1% ointment 15 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Aureocort ointment (Goldshield Healthcare Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Framycetin 0.5% eye ointment 5 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Soframycin 0.5% eye ointment (Florizel Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Nystaform HC ointment 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Nystaform HC ointment (Typharm Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Benzoic acid compound ointment 50 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Benzoic acid compound ointment 500 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Thornton & Ross Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Benzoic acid compound ointment (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid 15 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid 500 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid 2 kg Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid 3 kg Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid 4.5 kg Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (Adams Healthcare) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (Kent Pharma (UK) Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (J M Loveridge Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (Thornton & Ross Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Yellow soft paraffin solid (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polymyxin B 10,000units/g / Bacitracin 500units/g ointment 20 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polyfax ointment (Pliva Pharma Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Betamethasone 0.1% eye ointment 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Betnesol 0.1% eye ointment (Celltech Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polymyxin B 10,000units/g / Bacitracin 500units/g eye ointment 4 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polyfax ophthalmic ointment (Pliva Pharma Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polymyxin B 10,000units/g / Trimethoprim 5mg/g eye ointment 4 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polytrim ophthalmic ointment (Pliva Pharma Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Dibrompropamidine 0.15% eye ointment 5 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Brolene 0.15% eye ointment (Thornton & Ross Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Golden Eye 0.15% ointment (Typharm Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 2.5% eye ointment 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 2.5% eye ointment (Martindale Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 2.5% eye ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Martindale Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 0.5% eye ointment (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Allantoin 0.5% / Lidocaine 0.5% ointment 25 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Anodesyn ointment (Thornton & Ross Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Clioquinol 3% / Fluocinolone 0.025% ointment 15 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Synalar C ointment (GP Pharma) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment 25 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Shark liver oil 3% / Yeast cell extract 1% ointment 25 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Shark liver oil 3% / Yeast cell extract 1% ointment 50 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Preparation H ointment (Haleon UK Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Atropine 1% eye ointment 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Martindale Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Gregoderm ointment 15 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Gregoderm ointment (Unigreg Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1.5% / Neomycin 0.5% ear/eye ointment 3.9 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neo-Cortef ear/eye ointment (Pliva Pharma Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (Martindale Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 25 ml Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 55 ml Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Germoloids ointment (Bayer Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neomycin 0.5% eye ointment 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neomycin 0.5% eye ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neomycin 0.5% eye ointment (Martindale Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neomycin 0.5% eye ointment (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone 0.1% eye ointment 3 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Betnesol-N eye ointment (Celltech Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 15% / Ichthammol 1% ointment 500 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Special ointment No.1 (A A H Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Special ointment No.1 (Thornton & Ross Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Special ointment No.1 (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrocortisone 1% eye ointment (Unichem Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydromol ointment (Ferndale Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Maxitrol eye ointment 3.5 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Maxitrol eye ointment (Alcon Laboratories (UK) Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Fluocortolone 0.25% / Fluocortolone hexanoate 0.25% ointment 50 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Ultralanum Plain ointment (Meadow Laboratories) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic TCP antiseptic ointment 14 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic TCP antiseptic ointment 30 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
TCP antiseptic ointment (Pfizer Consumer Healthcare) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Antazoline 2% ointment 15 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Wasp-Eze Insect Bite 2% ointment (SSL International Plc) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Antipeol ointment 18 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Antipeol ointment 37 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Antipeol ointment 93 gram Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Antipeol ointment (Aspar Pharmaceuticals Ltd) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 15 ml Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier

Start Previous Page 8 of 64 Next End

This concept is not in any reference sets

Back to Start